BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+26.67%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$458M
AUM Growth
+$458M
(-5.6%)
Cap. Flow
-$103M
Cap. Flow
% of AUM
-22.54%
Top 10 Holdings %
Top 10 Hldgs %
55.71%
Holding
50
New
3
Increased
9
Reduced
24
Closed
7
Top Buys
| 1 |
PETX
Aratana Therapeutics, Inc.
PETX
|
$11.4M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$8.17M |
| 3 |
Myriad Genetics
MYGN
|
$7.97M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$6.05M |
| 5 |
Matinas BioPharma
MTNB
|
$2.97M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$32.8M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$15.4M |
| 3 |
DexCom
DXCM
|
$13.4M |
| 4 |
ADMA Biologics
ADMA
|
$10.4M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
$9.04M |
Sector Composition
| 1 | Healthcare | 87.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Iovance Biotherapeutics
IOVA
$807M
| $41.2M | 8.5% | 4,328,303 -1,622,850 | -27% | -$15.4M |
|
|
NVRO
2
DELISTED
NEVRO CORP.
NVRO
| $38.9M | 8.04% | 622,615 -121,800 | -16% | -$7.61M |
|
3
Catalyst Pharmaceutical
CPRX
$2.52B
| $29.9M | 6.17% | 5,856,998 -411,300 | -7% | -$2.1M |
|
|
PETX
4
DELISTED
Aratana Therapeutics, Inc.
PETX
| $26.1M | 5.4% | 7,258,135 +3,175,000 | +78% | +$11.4M |
|
|
BDSI
5
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $23.2M | 4.79% | 4,375,066 | – | – |
|
6
Travere Therapeutics
TVTX
$1.56B
| $23M | 4.75% | 1,016,114 | – | – |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $20.9M | 4.32% | 395,309 +154,400 | +64% | +$8.17M |
|
|
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
| $20.4M | 4.22% | 371,698 -164,300 | -31% | -$9.04M |
|
|
ADMS
9
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $17.6M | 3.63% | 2,469,894 -144,574 | -6% | -$1.03M |
|
|
SBBP
10
DELISTED
Strongbridge Biopharma plc.
SBBP
| $13.9M | 2.87% | 2,792,049 -29,673 | -1% | -$148K |
|
|
LJPC
11
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $12.8M | 2.65% | 1,994,911 +47,370 | +2% | +$305K |
|
|
BHVN
12
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $12.7M | 2.62% | 246,900 +117,600 | +91% | +$6.05M |
|
13
Aclaris Therapeutics
ACRS
$209M
| $12.2M | 2.51% | 2,030,925 +153,423 | +8% | +$919K |
|
|
SCTL
14
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $11.2M | 2.31% | 1,909,995 -138,030 | -7% | -$809K |
|
|
MRTX
15
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $10.9M | 2.24% | 148,100 -51,900 | -26% | -$3.8M |
|
|
QTNT
16
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $9.9M | 2.04% | 1,098,656 -598,926 | -35% | -$5.4M |
|
17
Incyte
INCY
$16.5B
| $8.6M | 1.78% | 100,000 -83,300 | -45% | -$7.16M |
|
|
NSTG
18
DELISTED
NanoString Technologies, Inc.
NSTG
| $8.51M | 1.76% | 355,714 -364,886 | -51% | -$8.73M |
|
|
XENT
19
DELISTED
Intersect ENT, Inc
XENT
| $8.47M | 1.75% | 263,500 -24,400 | -8% | -$785K |
|
|
SRRA
20
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $8.26M | 1.71% | 4,829,832 -50,495 | -1% | -$86.3K |
|
21
Strata Skin Sciences
SSKN
$9.93M
| $8.17M | 1.69% | 2,866,323 +694,960 | +32% | +$1.98M |
|
|
22
DexCom
DXCM
$29.5B
| $8.04M | 1.66% | 67,500 -112,400 | -62% | -$13.4M |
|
|
ATRS
23
DELISTED
Antares Pharma, Inc.
ATRS
| $8.01M | 1.65% | 2,643,947 -800,200 | -23% | -$2.42M |
|
|
24
Myriad Genetics
MYGN
$593M
| $7.97M | 1.65% | +240,000 | New | +$7.97M |
|
25
Integra LifeSciences
IART
$1.18B
| $7.89M | 1.63% | 141,572 -55,000 | -28% | -$3.06M |
|